Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-08-001488
Filing Date
2008-03-17
Accepted
2008-03-17 17:27:45
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c72713e10vk.htm 10-K 717075
2 EXHIBIT 10.30 c72713exv10w30.htm EX-10.30 67234
3 EXHIBIT 10.31 c72713exv10w31.htm EX-10.31 2814
4 EXHIBIT 10.32 c72713exv10w32.htm EX-10.32 7157
5 EXHIBIT 23.1 c72713exv23w1.htm EX-23.1 1647
6 EXHIBIT 31.1 c72713exv31w1.htm EX-31.1 8278
7 EXHIBIT 31.2 c72713exv31w2.htm EX-31.2 8286
8 EXHIBIT 32.1 c72713exv32w1.htm EX-32.1 4088
9 EXHIBIT 32.2 c72713exv32w2.htm EX-32.2 4101
10 GRAPHIC c72713c7271301.gif GRAPHIC 10594
  Complete submission text file 0001362310-08-001488.txt   836960
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 08694164
SIC: 2836 Biological Products, (No Diagnostic Substances)